SynthesisFrontiers in pharmacology2026
Ethnopharmacology and ecosystem applications of woody plant species in the Southern European Alps: a systematic review.
Synthesis in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alpine woody plants are deeply embedded in traditional healthcare systems across the Southern European Alps, where multiple organs-including leaves, bark, fruits, buds, and flowers-are used to manage respiratory, musculoskeletal, gastrointestinal, dermatological, metabolic, cardiovascular, and urogenital disorders. This systematic review synthesizes ethnopharmacological uses, evaluates phytochemical and pharmacological evidence, and contextualizes the ecosystem functions of woody plant species native to the European Alps. Methods: Following PRISMA guidelines, Web of Science, Scopus, and PubMed were systematically searched for peer-reviewed studies published up to May 2025. Data from 281 eligible sources were harmonized, covering 54 woody species (28 trees, 26 shrubs; 25 families). Extracted variables included ecological distribution, harvested organs, phytochemical classes, and experimentally validated bioactivities. Therapeutic indications were mapped using the International Classification of Primary Care (ICPC-2). Results: Phytochemical profiles were predominantly characterized by phenolic acids, flavonoids, anthocyanins, tannins, terpenoids, alkaloids, and saponins. These compounds underpin convergent anti-inflammatory, antimicrobial, antioxidant, antidiabetic, vasoprotective, and cytotoxic activities demonstrated in vitro and in vivo. Beyond medicinal relevance, the same species contribute to soil stabilization, hydrological regulation, carbon sequestration, and the preservation of biocultural landscapes. However, climate-driven range shifts, land-use intensification, commercial overharvesting, and limited pharmacokinetic and toxicological data constrain both sustainability and clinical translation. Discussion: High-priority taxa and critical knowledge gaps were identified. An integrated research framework is proposed, combining standardized green extraction technologies, high-resolution metabolomics, longitudinal ecological monitoring, participatory documentation of traditional knowledge, and equitable benefit-sharing mechanisms. Such integration is necessary to advance evidence-based phytotherapy while ensuring sustainable stewardship of Alpine woody ecosystems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.